Affordable Healthcare Reforms
- All
- News
- Videos
-
Budget 2026: Middle Class Set To Gain From Affordable Healthcare, Says Dr Jitendra Singh
Affordable drugs, vaccines and diagnostics, supported by domestic biomanufacturing, would be a major social and economic support, especially for the middle class and vulnerable sections, said Union Minister of State.
-
Budget 2026: Mental Healthcare Spending Set To Increase In Ranchi's Central Institute Of Psychiatry
The Union Budget has delivered a major boost to mental healthcare infrastructure in Jharkhand, with the Central Institute of Psychiatry (CIP), Ranchi, set to be upgraded as a regional apex institution.
-
Union Budget 2026: Health Allocation Raised To Rs 1.06 Lakh Crore
The National Health Mission has been allocated Rs 39,390 crore, aimed at strengthening primary healthcare, maternal and child health services, and disease control programmes.
-
9% Increase In Healthcare Budget Reflects Government's Commitment To Make It Accessible, Says Union Health Minister
Union Health Minister J.P. Nadda stated that the 176 per cent increase in the health sector budget over the past 12 years reflects the Modi government's commitment to making healthcare accessible to all.
-
Union Budget 2026: Enhanced Healthcare Allocations Explained
The Union Budget 2026-27 on Sunday enhanced the allocation for the Ministry of Health; Family Welfare to Rs 1,05,530.42 crores, reflecting an increase of 8.96 per cent over the Revised Estimates of FY 2025-26.
-
Budget 2026: Experts Call For Tax-Funded Universal Health Care And Better Resources At Government Hospitals
Health experts on Tuesday urged the government to introduce tax-funded Universal Health Care, and boost resources at government hospitals in the upcoming Union Budget 2026.
-
Indian Pharmaceutical Industry Transformed By GST Reforms And Research Development In 2025
With GST reforms and Research Development Incentive (RDI) Scheme, the year 2025 has been a crucial turning point for Indian pharma, said industry experts on Thursday.
-
New Study Highlights Drug Pricing And Regulation Issues In India
A new government study exposes serious flaws in India's drug pricing and regulation infrastructure. This study reveals how systemic failures impact drug pricing.
-
Budget 2026: Middle Class Set To Gain From Affordable Healthcare, Says Dr Jitendra Singh
Affordable drugs, vaccines and diagnostics, supported by domestic biomanufacturing, would be a major social and economic support, especially for the middle class and vulnerable sections, said Union Minister of State.
-
Budget 2026: Mental Healthcare Spending Set To Increase In Ranchi's Central Institute Of Psychiatry
The Union Budget has delivered a major boost to mental healthcare infrastructure in Jharkhand, with the Central Institute of Psychiatry (CIP), Ranchi, set to be upgraded as a regional apex institution.
-
Union Budget 2026: Health Allocation Raised To Rs 1.06 Lakh Crore
The National Health Mission has been allocated Rs 39,390 crore, aimed at strengthening primary healthcare, maternal and child health services, and disease control programmes.
-
9% Increase In Healthcare Budget Reflects Government's Commitment To Make It Accessible, Says Union Health Minister
Union Health Minister J.P. Nadda stated that the 176 per cent increase in the health sector budget over the past 12 years reflects the Modi government's commitment to making healthcare accessible to all.
-
Union Budget 2026: Enhanced Healthcare Allocations Explained
The Union Budget 2026-27 on Sunday enhanced the allocation for the Ministry of Health; Family Welfare to Rs 1,05,530.42 crores, reflecting an increase of 8.96 per cent over the Revised Estimates of FY 2025-26.
-
Budget 2026: Experts Call For Tax-Funded Universal Health Care And Better Resources At Government Hospitals
Health experts on Tuesday urged the government to introduce tax-funded Universal Health Care, and boost resources at government hospitals in the upcoming Union Budget 2026.
-
Indian Pharmaceutical Industry Transformed By GST Reforms And Research Development In 2025
With GST reforms and Research Development Incentive (RDI) Scheme, the year 2025 has been a crucial turning point for Indian pharma, said industry experts on Thursday.
-
New Study Highlights Drug Pricing And Regulation Issues In India
A new government study exposes serious flaws in India's drug pricing and regulation infrastructure. This study reveals how systemic failures impact drug pricing.
